ZANGANEH MAHKAM purchased 1.0% of their position (5K shares) of SUMMIT THERAPEUTICS INC. on the open market
Open‑market purchase worth $10.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/13/2023ACC: 0001599298-23-000103
+5K
Net shares
Net buyer
$1.21M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
810.50K acquired · 805.50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+489.81K
Price / share
$1.44
Trade value
$705.33K
% of position
New position
12/11/2023
0.00→489.81K
Common Stock
Indirect
Shares
+315.68K
Price / share
$1.58
Trade value
$498.78K
% of position
1.3%
12/11/2023
24.57M→24.89M
Common Stock
Direct
Shares
+5K
Price / share
$2.07
Trade value
$10.35K
% of position
1.0%
12/12/2023
489.81K→494.81K
Total
Net shares
+810.50K
Net value
$1.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2023 | X · X | +489.81K | $1.44 | $705.33K | New position | 0.00 | 489.81K |
| Common Stock Indirect | 12/11/2023 | X · X | +315.68K | $1.58 | $498.78K | 1.3% | 24.57M | 24.89M |
| Common Stock Direct | 12/12/2023 | P · Purchase | +5K | $2.07 | $10.35K | 1.0% | 489.81K | 494.81K |
| Total | +810.50K | $1.21M | ||||||
Derivative Transactions2
Warrant (right to buy)
Direct
Converts to
Common Stock
489.81K shares
Shares
−489.81K
Strike price
1.44
Held after
0.00
Exercisable
—
12/11/2023
Warrant (right to buy)
Indirect
Converts to
Common Stock
315.68K shares
Shares
−315.68K
Strike price
1.58
Held after
0.00
Exercisable
—
12/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock489.81K shares | 12/11/2023 | X · X | −489.81K | 1.44 | — | 0.00 |
| Warrant (right to buy) Indirect | Common Stock315.68K shares | 12/11/2023 | X · X | −315.68K | 1.58 | — | 0.00 |